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Abstract
Calcium-dependent uncoupling of liver mitochondrial oxidative phosphorylation by a non-metabolizable long chain fatty
acyl analogue was compared with uncoupling induced by in vivo thyroid hormone treatment. L,LP-Methyl-substituted
hexadecane K,g-dioic acid (Medica 16) is reported here to induce a saturable 20^30% decrease in liver mitochondrial v8,
vpH and protonmotive force which proceeds in the presence of added Ca2 to cyclosporin A-sensitive mitochondrial
permeabilization. Ca2-dependent uncoupling by Medica 16 was accompanied by atractylate-enhanced, bongkrekic-
inhibited activation of mitochondrial Ca2 efflux. The direct mitochondrial effect exerted in vitro by Medica 16 is similar to
that induced by in vivo thyroid hormone treatment. Hence, the thyromimetic protonophoric activity of Medica 16 and the
uncoupling activity of TH converge onto components of the mitochondrial permeabilization transition pore. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
The mitochondrial uncoupling activity of long
chain fatty acids (LCFA) results in increase in mito-
chondrial state 4 respiration with a concomitant de-
crease in P/O ratio (reviewed in [1]). This activity
reported both in isolated mitochondria and cells is of
importance in modulating the e⁄ciency of energy
expenditure under variable physiological conditions
[2] as well as in promoting mitochondrial permeabil-
ity transition (MPT) (reviewed in [3,4]) under condi-
tions of ischemia-reperfusion damage [5].
Medica 16 is a long chain fatty acyl analogue con-
sisting of L,LP-methyl-substituted hexadecane K,g-di-
carboxylic acid (HOOC-CH2-C(CH3)2-(CH2)10-
C(CH3)2-CH2-COOH) [6]. Since the g-carboxyl sub-
stitution of Medica 16 interferes with its esteri¢cation
into lipids while the methyl substitutions exclude its
L-oxidation, this fatty acyl analogue may serve as a
model compound for modulatory e¡ects exerted by
LCFA independent of their role as substrates. Spe-
ci¢cally, Medica 16 may be used for analyzing the
intrinsic uncoupling activity of LCFA on oxidative
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phosphorylation under conditions where uncoupling
is not compromised by respiration of the putative
uncoupler. Medica 16 has indeed been recently re-
ported by us to induce in liver cells as well as in liver
and heart mitochondria a pronounced but saturable
decrease in mitochondrial protonmotive force (pmf)
with a concomitant increase in state 4 respiration
[7,8]. This uncoupling activity of Medica 16 was
found to be partially suppressed by atractyloside
[7], in line with recent studies indicating that the
protonophoric activity of LCFA may be accounted
for by inward spontaneous £ip-£op of the undissoci-
ated fatty acid followed by adenine nucleotide trans-
locase (ANT)-catalyzed e¥ux of the fatty acid anion
[9^12].
The mitochondrial uncoupling activity of LCFA
or fatty acyl analogues is similar in many respects
to that induced by treatment with thyroid hormones
(TH) (reviewed in [13]). Indeed, respiration is in-
creased while mitochondrial membrane potential is
decreased in liver cells incubated in the presence of
added long chain fatty acyl analogues [7] or derived
from TH-treated animals [14,15]. Furthermore, in
vivo treatment with either Medica 16 or TH results
in a pronounced increase in respiration accompanied
by decrease in liver phosphate and redox potentials
[16]. Hence, analyzing the protonophoric mode of
action of Medica 16 as compared with TH may point
to shared mitochondrial elements a¡ected by both
treatment modes.
Studies concerned with the protonophoric activity
of LCFA, fatty acyl analogues or TH were usually
performed in Ca2-free medium in order to avoid
Ca2-dependent activation of mitochondrial oxida-
tion of the fatty acid substrate (reviewed in [17]) as
well as Ca2-dependent activation of the MPT pore
[18^21]. However, Ca2 involvement in the protono-
phoric activity of LCFA or TH could be of partic-
ular interest in light of recent ¢ndings indicating that
the channel activity of mitochondrial ANT [22] as
well as that of the low conductance MPT pore [23]
might be reversibly modulated by Ca2. The non-L-
oxidizable Medica 16 combined with gating of the
MPT pore by cyclosporin A (CSA) [24] makes it
possible to analyze the protonophoric activity of
LCFA or TH in the presence of added Ca2 and
to dissect steps leading from low to high mitochon-
drial conductance.
2. Experimental procedures
Male albino rats weighing 150^180 g were fed a
standard Purina laboratory chow diet (Ralston-Puri-
na, St. Louis, MO). Hyperthyroidism was induced by
daily injection of L-T3 (50 Wg/100 g BW in 0.05 N
NaOH in saline) for 5 days. Control animals were
injected with the vehicle alone. Hypothyroidism was
induced by adding 0.025% w/v methimazole to the
drinking water for 4 weeks.
Rat liver mitochondria were prepared by standard
methods in a medium containing 250 mM sucrose,
5 mM Tris (pH 7.4), and 1 mM EGTA. Mitochon-
drial pellets were washed twice in a medium contain-
ing 250 mM sucrose and 1 mM [3-(N-morpholino)-
propanesulfonic acid]-Na bu¡er, pH 7.4, to remove
EGTA. The washed pellets were dissolved in the
same medium at a ¢nal protein concentration of 50
mg protein/ml and kept in ice for not more than 4 h.
Mitochondrial membrane potential (vi) and pro-
ton gradient (vpH) were measured as described by
[25] using 86Rb (in the presence of valinomycin) and
[14C]acetate, respectively. Total, extra- and intrami-
tochondrial spaces were measured by following the
distribution of 3H2O together with either
[14C]sucrose or [14C]inulin [25]. Inulin, with a molec-
ular mass of 5200 Da, does not penetrate the MPT
pore and allows for measuring mitochondrial space
under conditions of MPT [26]. A calibration factor
for the inulin space was derived by correlating the
sucrose and inulin spaces of mitochondria incubated
in the presence of EGTA and variable sucrose con-
centrations in the range of 50^250 mM, as previously
described [25]. For mitochondrial vi and vpH mea-
surements, 2^2.5 mg mitochondrial protein were in-
cubated at 30‡C for 7 min in 1.5 ml plastic vials
containing 1 ml reaction mixture composed of 250
mM sucrose, 5 mM HEPES (pH 7.2), 5 mM succi-
nate, 5 WM rotenone, 0.6 Wg/ml oligomycin, 320 pmol
valinomycin/mg mitochondrial protein, 0.5 WCi
86Rb (0.16 WCi/nmol), 0.36 WCi [14C]acetate (0.05
WCi/mmol), 2 WCi 3H2O, either 0.45 WCi [14C]sucrose
(0.01 WCi/nmol) or 0.6 WCi [14C]inulin (0.13 WCi/
mmol). 20 nmol Ca2/mg mitochondrial protein,
1 mM EGTA or 1 Wg CSA/mg mitochondrial pro-
tein were added where indicated. After incubation,
the mitochondrial suspension was transferred to a
1.5 ml Eppendorf microfuge tube containing 150 Wl
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silicon oil (approx. 0.99^1.05 density) and centri-
fuged at 12 000Ug for 2 min at 4‡C. Aliquots of
the mitochondrial and mitochondrial-free fractions
were transferred to 1.5 N HClO4, the perchloric
acid extracts were centrifuged, and aliquots of the
perchloric acid supernatants were counted in Quick-
safe A scintillation £uid. vi, vpH and pmf were
calculated as previously described [25].
Mitochondrial Ca2 in£ux and e¥ux were mea-
sured by following the free Ca2 concentration in
the incubation medium using a Ca2 electrode (OR-
ION Ca2 electrode, Model 93-20) calibrated as de-
scribed by Bers [27]. Ca2 in£ux was measured at
30‡C in 1 ml incubation medium containing
250 mM sucrose, 5 mM HEPES (pH 7.4), 10 mM
succinate, 5 WM rotenone, 0.8^1.25 mg mitochon-
drial protein/ml reaction mixture, 20 nmol Ca2/mg
mitochondrial protein, and 1^2 Wg CSA/mg mito-
chondrial protein. For Ca2 e¥ux determinations,
mitochondria were ¢rst preloaded for 2 min by
Ca2 at 30‡C in an incubation medium containing
250 mM sucrose, 5 mM HEPES (pH 7.4), 10 mM
succinate, 5 WM rotenone, 0.8^1.25 mg mitochon-
drial protein/ml reaction mixture, 20 nmol Ca2/mg
mitochondrial protein and 1^2 Wg of CSA/mg mito-
chondrial protein. Following Ca2 loading, Ca2 ef-
£ux was measured in the presence of added 2 nmol
ruthenium red/mg mitochondrial protein.
Mitochondrial swelling was spectrophotometri-
cally measured by determining the apparent absor-
bance at 540 nm in 1 ml incubation medium contain-
ing 250 mM sucrose, 5 mM HEPES (pH 7.2), 10 mM
succinate, 5 Wm rotenone, 0.6 Wg/ml oligomycin,
0.35^0.75 mg of mitochondrial protein/ml reaction
mixture, 20 nmol Ca2/mg mitochondrial protein,
and EGTA, CSA or ruthenium red as indicated.
Statistical analysis for the comparison of two
groups was performed by Student’s t-test.
3. Results
3.1. Ca2+ dependence of the protonophoric activity of
Medica 16
The e¡ect of Medica 16 on proton gradient, mem-
brane potential and mitochondrial pmf in isolated
liver mitochondria was evaluated in the absence
and presence of added Ca2. As shown in Fig. 1A,
and in line with our previous results [7], adding
Medica 16 to mitochondria respiring on succinate
in the absence of Ca2 (added EGTA) resulted in a
saturable, concentration dependent, 20^30% decrease
of mitochondrial vpH, vi and pmf. The EC50 for
the uncoupling e¡ect of Medica 16 amounted to
Fig. 1. Medica 16-induced decrease in mitochondrial proton
gradient, membrane potential and protonmotive force. Mito-
chondrial vpH (b), vi (F) and vp (R) were measured as de-
scribed in Section 2 in liver mitochondria incubated in the pres-
ence of 20 nmole Ca2/mg mitochondrial protein and Medica
16 as indicated. Values are expressed as percent of basal respec-
tive values (100%) measured in the absence of added Medica
16. Each value is the mean þ S.E. of three independent experi-
ments. (A) In the presence of 1 mM EGTA. Basal values
amounted to 69 þ 6, 171 þ 3 and 242 þ 5 mV for vpH, vi and
vp, respectively. (B) In the presence of 1 Wg CSA/mg mitochon-
drial protein. Basal values amounted to 62 þ 4 mV, 165 þ 5 mV
and 227 þ 8 mV for vpH, vi and vp, respectively.
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11.5 nmol/mg protein. Adding Ca2 (20 nmol/mg
mitochondrial protein) while gating the MPT pore
by CSA resulted in amplifying the protonophoric
activity of Medica 16, amounting to 50^60% decrease
in mitochondrial pmf under conditions of saturation
with Medica 16 (Fig. 1B). The EC50 for Medica 16
remained una¡ected by added Ca2. These results
were further con¢rmed by measuring the protono-
phoric activity of saturating Medica 16 in rat liver
mitochondria preloaded with increasing concentra-
tions of Ca2 under conditions of gating the MPT
pore by CSA (Fig. 2). Mitochondrial vpH was
slightly increased and vi and pmf remained essen-
tially una¡ected by increasing Ca2 concentrations in
the absence of added Medica 16. Increase in mito-
chondrial vpH could re£ect Ca2 accumulation by
energized mitochondria at the expense of H extru-
sion. Increasing Ca2 concentrations in the presence
of added Medica 16 resulted, however, in a pro-
nounced decrease in mitochondrial vi and pmf as
function of added Ca2. The Medica 16/Ca2 inter-
play may therefore indicate that Ca2 is involved in
the protonophoric activity of Medica 16, and that
the uncoupling activity observed in its absence (Fig.
1A) could be accounted for by endogenous mito-
chondrial Ca2.
Fig. 3. Inhibition of mitochondrial Ca2 in£ux by Medica 16.
Mitochondrial Ca2 in£ux was determined as described in Sec-
tion 2 in the absence (F) and presence of 10 (R) or 20 (b)
nmol Medica 16/mg mitochondrial protein. One representative
experiment out of four.
Table 1
The e¡ect of TH treatment on mitochondrial proton gradient, membrane potential and protonmotive force
EGTA CSA
vpH vi vp vpH vi vp
Euthyroid 62.8 þ 5.5 175.5 þ 4.3 238.3 þ 9.6 58.3 þ 3.7 143.5 þ 14.3 201.8 þ 17.9
Hyperthyroid 50.8 þ 5.0 147.5 þ 6.3* 198.3 þ 1.6* 50.0 þ 7.3 107.0 þ 18.1 157.0 þ 23.5
Mitochondrial vpH, vi and vp in mV were measured as described in Section 2 in mitochondria isolated from euthyroid or hyperthy-
roid rats and incubated in the presence of 20 nmol Ca2/mg mitochondrial protein, and either 1 mM EGTA or 1 Wg CSA/mg mito-
chondrial protein as indicated. Each value is the mean þ S.E. of three independent experiments.
*Signi¢cantly di¡erent from the respective euthyroid value, P6 0.05.
Fig. 2. Ca2 dependence of the protonophoric activity of Medi-
ca 16. Mitochondrial vpH (b,a), vi (F,E) and vp (R,O) were
measured as described in Section 2 in liver mitochondria incu-
bated in the presence (closed symbols) or absence (open sym-
bols) of 20 nmol Medica 16/mg mitochondrial protein, 1 Wg
CSA/mg mitochondrial protein and added Ca2 as indicated.
Values are expressed as percent of basal respective values
(100%) measured in the absence of Medica 16 and in the pres-
ence of 10 nmol Ca2/mg protein. Basal values amounted to
54, 171 and 225 mV for vpH, vi and vp, respectively. Means
of two independent experiments.
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The Medica 16/Ca2 interplay was further ana-
lyzed in terms of e¡ects exerted by Medica 16 on
mitochondrial Ca2 in£ux and e¥ux under condi-
tions of gating the MPT pore by CSA. Mitochon-
drial Ca2 in£ux catalyzed by the Ca2 uniporter
and driven by mitochondrial pmf (reviewed in [28]),
was indeed inhibited by added Medica 16 (Fig. 3),
thus presumably re£ecting the consequence of its
protonophoric activity. Liver mitochondrial Ca2 ef-
£ux catalyzed by the Na-independent (Ca2/2H ex-
change) transporter [28] was expected to be similarly
inhibited by Medica 16 as a result of its uncoupling
activity. However, as shown in Fig. 4, mitochondrial
Ca2 e¥ux was pronouncedly activated by added
Medica 16, being further modulated by the confor-
mation of ANT. Promoting the C (cytosolic) or M
(matrix) ANT conformations by atractylate or
bongkrekic acid respectively [29], resulted in activa-
tion or inhibition of Medica 16-induced Ca2 e¥ux,
respectively. Mitochondrial Ca2 e¥ux in the ab-
sence of added Medica 16 remained una¡ected by
atractylate or bongkrekic acid thus indicating that
ANT was speci¢cally involved in Ca2 e¥ux induced
by Medica 16.
3.2. Ca2+ dependence of the uncoupling activity of
thyroid hormones
The mitochondrial uncoupling activity of TH as
function of Ca2 was evaluated in liver mitochondria
derived from hyperthyroid as compared with euthy-
roid animals. As shown in Table 1, in vivo TH treat-
ment resulted in 15% decrease in mitochondrial vi
and pmf in the absence of added Ca2 (added
Fig. 5. Mitochondrial Ca2 e¥ux in eu-, hyper- and hypothy-
roid rats. Mitochondrial Ca2 e¥ux was determined as de-
scribed in Section 2 in mitochondria derived from euthyroid
(R), hyperthyroid (F) or hypothyroid (b) rats. One representa-
tive experiment out of four.
Table 2
Mitochondrial permeabilization transition by Medica 16 or by in vivo TH treatment
vpH vi vp
Euthyroid 55.7 þ 4.3 135.3 þ 16.4 191.0 þ 19.9
Euthyroid+Medica 16 21.0 þ 7.4* 28.3 þ 11.9* 49.3 þ 18.9*
Hyperthyroid 30.7 þ 1.2* 25.3 þ 2.6* 56.0 þ 3.6*
Mitochondrial vpH, vi and vp in mV were measured as described in Section 2 in mitochondria isolated from euthyroid or hyperthy-
roid rats and incubated in the presence of 20 nmol Ca2/mg mitochondrial protein. 10 nmol Medica 16/mg mitochondrial protein
were added as indicated. Each value is the mean þ S.E. of three independent experiments.
*Signi¢cantly di¡erent from the respective euthyroid value, P6 0.05.
Fig. 4. Activation of mitochondrial Ca2 e¥ux by Medica 16.
Mitochondrial Ca2 e¥ux was determined as described in Sec-
tion 2 in the absence (open symbols) and presence (closed sym-
bols) of 20 nmol Medica 16/mg mitochondrial protein. E,F, no
further additions; R, 16 nmol bongkrekic acid/mg mitochon-
drial protein; b, 30 or 8, 50 nmol atractylate/mg mitochon-
drial protein. One representative experiment out of four.
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EGTA). Adding Ca2 to hyperthyroid mitochondria
while gating the MPT pore by CSA resulted in fur-
ther decrease in vi and pmf, thus indicating that in
vivo TH treatment acted synergistically with mito-
chondrial Ca2 in mitochondrial uncoupling.
Similarly to the protonophoric activity of Medica
16, the uncoupling activity induced by in vivo TH
treatment was characterized by activation of Ca2
e¥ux in hyperthyroid mitochondria and its suppres-
sion in hypothyroid mitochondria under conditions
of gating the MPT pore by CSA (Fig. 5).
3.3. Mitochondrial permeability transition by Medica
16 and TH
In the presence of added Ca2 and in the absence
of CSA, uncoupling of oxidative phosphorylation by
added Medica 16 or by in vivo TH treatment re-
sulted in mitochondrial swelling and collapse of mi-
tochondrial pmf (Table 2, Fig. 6). Ca2-dependent
collapse of mitochondrial pmf could be partially pre-
vented by added CSA, or by abrogating mitochon-
drial Ca2 cycling by ruthenium red (Fig. 6). Swell-
ing resulted in 30^35% increase in mitochondrial
volume (not shown).
4. Discussion
Replacing LCFA by the non-L-oxidizable Medica
16 makes it possible to analyze the role of Ca2 in
the protonophoric activity of LCFA independently
of their mitochondrial oxidation. In the absence of
Ca2 (added EGTA) Medica 16 induces a saturable
20^30% decrease in mitochondrial pmf (Fig. 1A)
with a concomitant pronounced decrease of mito-
chondrial pH (8). This protonophoric activity may
be ascribed to inward £ip-£op of the undissociated
acid followed by ANT-mediated e¥ux of the fatty
acyl anion [9], as previously veri¢ed in reconstituted
ANT systems [10], ANT-de¢cient yeast mutants [30],
by using ANT inhibitors [20,31] or azido fatty acids
[32]. The inward £ip-£op of the dicarboxylic Medica
16 requires the L,LP-substituted methyl groups for
shielding the g-carboxyl function [8,33,34]. Comple-
menting the protonophoric activity of Medica 16 by
added Ca2 results in transition to CSA-sensitive mi-
tochondrial permeabilization catalyzed by the MPT
pore (Fig. 6A) in line with previous reports of Ca2-
dependent activation of the MPT pore by LCFA
[20]. As ANT constitutes an integral component of
the MPT pore and since the ANT/MPT pore may be
reversibly converted by Ca2 into a channel [22,35^
39], the e¡ect of added Medica 16/Ca2 may be as-
cribed to ANT transition from a low to a high con-
ductance channel, resulting in mitochondrial perme-
Fig. 6. Induction of Ca2-dependent mitochondrial swelling by
Medica 16 (A) or by in vivo thyroid hormone treatment (B).
(A) Mitochondrial swelling was determined at 30‡C as de-
scribed in Section 2 in the absence (open symbols) and presence
(closed symbols) of 10 nmol Medica 16/mg mitochondrial pro-
tein. E,F, no further additions; 8, 2 nmol ruthenium red/mg
mitochondrial protein; R, 1 mM EGTA; b, 1 Wg CSA/mg mi-
tochondrial protein. Each value is the mean þ S.E. of three in-
dependent experiments. (B) Mitochondrial swelling was deter-
mined at 35‡C as described in Section 2 in mitochondria
isolated from euthyroid (open symbols) or hyperthyroid (closed
symbols) rats. E,F, no further additions; O,R, 1 mM EGTA;
a,b, 1 Wg CSA/mg mitochondrial protein. One representative
experiment out of ¢ve.
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abilization. Mitochondrial permeabilization by Medi-
ca 16/Ca2 is only partially inhibited by CSA (Fig.
1B and 2) since gating of the MPT pore by CSA is
competed by Ca2 [40^42]. The transition from the
physiological low conductance ANT to high conduc-
tance mitochondrial permeabilization state may
therefore be visualized as a continuous sequel where
the extent of transition may be modulated by the
interplay between LCFA, Ca2, ANT openers (e.g.,
cyclophilin D) and ANT blockers (e.g., CSA-like fac-
tors). Transition could be mediated by recruiting
ANT/MPT pores of a given conductance or by mod-
ulating the conductance level of given pores.
Mitochondrial permeabilization by Medica 16/
Ca2 is accompanied by activation of mitochondrial
Ca2 e¥ux. Since the Na-independent mitochon-
drial Ca2 transporter is energy- and vpH-dependent
[28], uncoupling by Medica 16 makes it unlikely that
this transporter accounts for Medica 16-induced
Ca2 e¥ux. Alternatively, as Medica 16-induced
Ca2 e¥ux is modulated by ANT inhibitors (Fig.
4), and since main characteristics of the ANT chan-
nel are identical with those of the MPT pore (e.g.,
Ca2 dependence, inhibition by bongkrekic acid or
ADP and activation by atractylate), Ca2 e¥ux is
proposed to involve the ANT/MPT pore which
may allow for e¥ux of both, the LCFA (or Medica
16) anion as well as Ca2. E¥ux of Ca2 and the
fatty acyl anion through the ANT/MPT pore could
perhaps re£ect e¥ux of the LCFA-Ca2 or Medica
16-Ca2 complex.
Characteristics of mitochondrial uncoupling by in
vivo TH treatment appear to be very similar to the
protonophoric activity of Medica 16. Uncoupling by
both is synergistic with added Ca2 (Fig. 2, Table 1),
mitochondrial Ca2 e¥ux is activated by both (Figs.
4 and 5), and the e¡ect exerted by both is modulated
by ANT inhibitors (Fig. 4, [1,7,8,31,43]), thus indi-
cating that both e¡ectors may converge onto the
ANT/MPT pore. Moreover, hypothyroidism has
been recently reported to induce resistance to MPT
in liver mitochondria [44]. However, and in spite of
the apparent convergence of both e¡ectors onto the
same or related mitochondrial elements, the two ef-
fectors di¡er with respect to their speci¢c mode of
action. In contrast to TH treatment, the mitochon-
drial protonophoric activity of Medica 16 was not
observed in mitochondria derived from rats treated
for 6 days with 0.25% (w/w) of Medica 16 and
studied in vitro in the absence of added Medica 16
[7], thus indicating that the Medica 16 e¡ect requires
its direct interaction with mitochondria while uncou-
pling by in vivo TH treatment is maintained and
preserved in mitochondria derived from TH-treated
rats and in the absence of TH added to the mito-
chondrial preparation. Hence, uncoupling by TH
may re£ect its transcriptional activity while that of
Medica 16 results from its mitochondrial cycling.
Uncoupling by TH could result from changing the
proportion of ANT units within the MPT pore com-
plex due to induction of ANT by TH [45]. Alterna-
tively, uncoupling by TH could result from TH in-
duction of other MPT components.
Treatment with TH results in 50% increase in total
body energy expenditure [46]. A similar but less pro-
nounced calorigenic activity has been reported for
Medica 16, amounting to 25% increase in total
body oxygen consumption [47]. However, since
Medica 16 is not transported into skeletal or cardiac
muscles (H. Bdeir, in preparation), its calorigenic
activity is mainly due to its liver activity, and the
lower increase in total body energy expenditure in-
duced by Medica 16 treatment as compared with TH
may be accounted for by its limited tissue speci¢city.
Indeed, liver phosphate and redox potentials taken
as indicators for coupling of mitochondrial oxidative
phosphorylation under in vivo conditions were pro-
nouncedly decreased by both TH or Medica 16 treat-
ment [48], thus indicating that Medica 16 may be
realized as a tissue speci¢c thyromimetic e¡ector.
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